Growth Metrics

Calidi Biotherapeutics (CLDI) Total Debt (2022 - 2025)

Calidi Biotherapeutics' quarterly Total Debt came in at $200000.0 in Q4 2025, down 10.31% year-on-year from $223000.0 in Q4 2024, and down 33.33% quarter-over-quarter from $300000.0 in Q3 2025.

Calidi Biotherapeutics has reported Total Debt for 4 years, with the latest figure at $200000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Total Debt fell 10.31% year-over-year to $200000.0; the trailing twelve-month figure through Dec 2025 stood at $200000.0 (down 10.31% YoY), and the FY2025 full-year result was $200000.0, down 10.31% from the prior year.
  • Total Debt for Q4 2025 stood at $200000.0, down from $300000.0 in the prior quarter.
  • The five-year high for Total Debt was $500.0 million in Q2 2025, with the low at $134269.0 in Q1 2023.
  • Average Total Debt over 4 years is $42.3 million, with a median of $248224.0 recorded in 2023.
  • Year-over-year, Total Debt plunged 92.65% in 2024 and surged 236866.82% in 2025.
  • Tracing CLDI's Total Debt over 4 years: stood at $1.0 million in 2022, then jumped by 106.0% to $2.1 million in 2023, then plunged by 89.17% to $223000.0 in 2024, then declined by 10.31% to $200000.0 in 2025.
  • The last three Total Debt figures came in at $200000.0 (Q4 2025), $300000.0 (Q3 2025), and $500.0 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn 319.10 Mn
4 Nanobiotix 2,282.79 Bn 2,282.72 Bn - 110.96 Mn
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 1.99 Bn
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn -
10 Calidi Biotherapeutics - - - 200,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 200,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 500.00 Mn
Dec 31, 2024 223,000.00
Sep 30, 2024 217,000.00
Jun 30, 2024 211,000.00
Mar 31, 2024 205,000.00
Dec 31, 2023 2.06 Mn
Sep 30, 2023 2.95 Mn
Jun 30, 2023 273,448.00
Mar 31, 2023 134,269.00
Dec 31, 2022 1.00 Mn